Ankang Lyu
197 Ruijiner Rd
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
Therapeutic potential and protective role of GRK6 overexpression in pulmonary arterial hypertension.
Journal: Vascular pharmacology
Published: June 05, 2023
Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition.
Journal: Cardiovascular research
Published: December 19, 2022
Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1β (Interleukin 1β) Production.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: April 07, 2022
Impact of Long-Term Home Quarantine on Mental Health and Physical Activity of People in Shanghai During the COVID-19 Pandemic.
Journal: Frontiers in psychiatry
Published: September 24, 2021
Tregs-derived interleukin 35 attenuates endothelial proliferation through STAT1 in pulmonary hypertension.
Journal: Annals of translational medicine
Published: March 29, 2021
Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages.
Journal: Circulation research
Published: September 11, 2020
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
Journal: American journal of respiratory and critical care medicine
Published: January 10, 2020
DP1 Activation Reverses Age-Related Hypertension Via NEDD4L-Mediated T-Bet Degradation in T Cells.
Journal: Circulation
Published: January 03, 2020
Macrophage-Derived Legumain Promotes Pulmonary Hypertension by Activating the MMP (Matrix Metalloproteinase)-2/TGF (Transforming Growth Factor)-β1 Signaling.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 25, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026